https://it.marketscreener.com/quotazioni/azione/APTEVO-THERAPEUTICS-INC-29774500/attualita/Aptevo-Therapeutics-Inc-annuncia-che-APVO436-in-combinazione-con-Venetoclax-e-Azacitidina-ha-ragg-42535302/?utm_source=telegram&utm_medium=social&utm_campaign=share